These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 17653496

  • 1. Neuropsychiatric outcome for clinical trials.
    Robert P, Verhey FR, Aalten P, Cortes F, Byrne EJ.
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.
    Frolich L.
    J Nutr Health Aging; 2007; 11(4):357-8. PubMed ID: 17653499
    [No Abstract] [Full Text] [Related]

  • 3. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F, Portet F, Touchon J, Vellas B.
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [Abstract] [Full Text] [Related]

  • 4. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S.
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [Abstract] [Full Text] [Related]

  • 5. Treatment for Alzheimer's disease.
    Wilcock GK.
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract] [Full Text] [Related]

  • 6. [Dementias: mostly clinico-neuropsychological or mostly psychometric diagnosis?].
    Spinnler H.
    Ann Ist Super Sanita; 2005 Jun; 41(1):75-80. PubMed ID: 16037654
    [Abstract] [Full Text] [Related]

  • 7. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC, Diehl LA, Hedgepath AW.
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract] [Full Text] [Related]

  • 8. Recognizing and evaluating potential dementia in office settings.
    Freund B, Gravenstein S.
    Clin Geriatr Med; 2004 Feb; 20(1):1-14. PubMed ID: 15062483
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG.
    Funct Neurol; 1997 Feb; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract] [Full Text] [Related]

  • 10. [Dementia--treatment].
    Stoppe G, Stiens G, Staedt J.
    Dtsch Med Wochenschr; 2003 Jul 11; 128(28-29):1544-6; quiz 147-50. PubMed ID: 12854065
    [No Abstract] [Full Text] [Related]

  • 11. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Gauthier S, Bodick N, Erzigkeit E, Feldman H, Geldmacher DS, Huff J, Mohs R, Orgogozo JM, Rogers S.
    Alzheimer Dis Assoc Disord; 1997 Jul 11; 11 Suppl 3():6-7. PubMed ID: 9305507
    [No Abstract] [Full Text] [Related]

  • 12. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, Kumar R, Lucca U, Mangone CA, Mohr E, Morris JC, Rogers S, Sawada T.
    Alzheimer Dis Assoc Disord; 1997 Jul 11; 11 Suppl 3():8-18. PubMed ID: 9305508
    [Abstract] [Full Text] [Related]

  • 13. [Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients].
    Shimabukuro J, Awata S, Matsuoka H.
    Seishin Shinkeigaku Zasshi; 2008 Jul 11; 110(7):529-35. PubMed ID: 18833901
    [No Abstract] [Full Text] [Related]

  • 14. [Dementia].
    Diehl RR.
    Fortschr Neurol Psychiatr; 2003 Nov 11; 71(11):617-28. PubMed ID: 14608514
    [No Abstract] [Full Text] [Related]

  • 15. Dementia treatment update.
    Buffum MD, Buffum JC.
    Geriatr Nurs; 2005 Nov 11; 26(2):74-8. PubMed ID: 15824717
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacological treatment in severe dementia].
    Jouanny P, Belliard S, Bentué-Ferrer D, Michel O, Allain H.
    Psychol Neuropsychiatr Vieil; 2005 Mar 11; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [Abstract] [Full Text] [Related]

  • 17. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
    Rosenblatt A, Samus QM, Onyike CU, Baker AS, McNabney M, Mayer LS, Brandt J, Lyketsos CG.
    Int J Geriatr Psychiatry; 2008 Feb 11; 23(2):178-84. PubMed ID: 17676652
    [Abstract] [Full Text] [Related]

  • 18. [Nursing strategy. Alzheimer's disease, early diagnosis and treatments].
    Amouyal-Barkate K, Voisin T, Andrieu S, Nourhashemi F, Vellas B.
    Soins Gerontol; 2002 Feb 11; (36):14-21. PubMed ID: 12154665
    [No Abstract] [Full Text] [Related]

  • 19. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH, Lucca U, Mohs R, Dubois B, Wesnes K, Erzigkeit H, Geldmacher D, Bodick N.
    Alzheimer Dis Assoc Disord; 1997 Feb 11; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract] [Full Text] [Related]

  • 20. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE.
    J Nutr Health Aging; 2007 Feb 11; 11(4):327-9. PubMed ID: 17653492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.